Evercore ISI Group Maintains In-Line on Zimmer Biomet Holdings, Raises Price Target to $130
Portfolio Pulse from Benzinga Newsdesk
Evercore ISI Group analyst Vijay Kumar maintains an In-Line rating on Zimmer Biomet Holdings (ZBH) and raises the price target from $125 to $130.
April 04, 2024 | 5:06 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Evercore ISI Group maintains an In-Line rating on Zimmer Biomet Holdings and raises the price target from $125 to $130.
The increase in price target by Evercore ISI Group suggests a positive outlook on the stock, potentially leading to increased investor confidence and a short-term upward movement in ZBH's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100